Pre-Congress Workshops




Panel discussion
April 14, 10:00 - 5:30


Trials and tribulations of integrating adjuvants into your vaccine. What’s the value of current and new adjuvants?
  • Value of current adjuvants & research gaps
  • Adjuvant technology and its impact on vaccine development
  • Precision adjuvants: Developing adjuvantation systems tailored to target populations
  • New adjuvants and overcoming formulation challenges
  • Designing and building the next generation of vaccine adjuvants Controlling vaccine kinetics with adjuvants for enhanced immunity
  • Lessons learned from approved adjuvanted vaccines
  • Perspectives of vaccine adjuvant discovery and development, and funding opportunities for adjuvant research
Elizabeth Sutkowski Elizabeth Sutkowski, Chief Of Regulatory Review Branch 3, FDA


Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington


To Sponsor Or Exhibit

Marc Rhys-Evans
+44 20 7827 5945




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071